Free Trial

Capital Fund Management S.A. Raises Holdings in Adient $ADNT

Adient logo with Auto/Tires/Trucks background

Key Points

  • Capital Fund Management S.A. increased its stake in Adient by 376.0%, purchasing an additional 175,987 shares, bringing its total ownership to 222,795 shares.
  • Adient's stock recently showed a performance increase of 5.4% and currently has a market capitalization of $2.02 billion with a price-to-earnings ratio of -9.38.
  • Wall Street analysts have mixed views on Adient, with target prices ranging from $17.50 to $27.00 and a consensus rating of "Reduce".
  • Want stock alerts on Adient? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Capital Fund Management S.A. raised its position in Adient (NYSE:ADNT - Free Report) by 376.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 222,795 shares of the company's stock after buying an additional 175,987 shares during the quarter. Capital Fund Management S.A. owned about 0.27% of Adient worth $2,865,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in ADNT. Northern Trust Corp boosted its holdings in shares of Adient by 6.8% in the 4th quarter. Northern Trust Corp now owns 1,129,645 shares of the company's stock worth $19,464,000 after purchasing an additional 72,077 shares in the last quarter. Y Intercept Hong Kong Ltd purchased a new position in shares of Adient in the 1st quarter worth about $1,036,000. Entropy Technologies LP purchased a new position in shares of Adient in the 1st quarter worth about $138,000. Man Group plc purchased a new position in shares of Adient in the 4th quarter worth about $704,000. Finally, Vanguard Group Inc. boosted its holdings in shares of Adient by 1.5% in the 1st quarter. Vanguard Group Inc. now owns 3,485,241 shares of the company's stock worth $44,820,000 after purchasing an additional 53,101 shares in the last quarter. 92.44% of the stock is currently owned by hedge funds and other institutional investors.

Adient Stock Down 1.8%

Shares of ADNT stock traded down $0.46 during midday trading on Friday, reaching $24.62. 412,606 shares of the stock were exchanged, compared to its average volume of 1,425,322. Adient has a 1 year low of $10.04 and a 1 year high of $25.84. The company's 50 day moving average is $22.32 and its two-hundred day moving average is $17.24. The company has a current ratio of 1.12, a quick ratio of 0.92 and a debt-to-equity ratio of 1.15. The firm has a market cap of $2.00 billion, a PE ratio of -9.29, a price-to-earnings-growth ratio of 0.85 and a beta of 1.72.

Adient (NYSE:ADNT - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported $0.45 earnings per share for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). Adient had a positive return on equity of 8.25% and a negative net margin of 1.53%.The firm had revenue of $3.74 billion for the quarter, compared to analysts' expectations of $3.56 billion. During the same quarter last year, the company posted $0.32 EPS. The firm's revenue was up .7% on a year-over-year basis. On average, equities research analysts predict that Adient will post 1.76 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on ADNT. Wall Street Zen raised Adient from a "hold" rating to a "buy" rating in a research note on Friday, July 18th. Bank of America boosted their target price on Adient from $15.00 to $17.50 and gave the company an "underperform" rating in a research note on Monday, June 16th. Zacks Research lowered Adient from a "strong-buy" rating to a "hold" rating in a research note on Monday, August 18th. UBS Group boosted their target price on Adient from $25.00 to $26.00 and gave the company a "neutral" rating in a research note on Thursday, August 7th. Finally, Barclays boosted their target price on Adient from $18.00 to $25.00 and gave the company an "equal weight" rating in a research note on Wednesday, July 16th. One investment analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Reduce" and a consensus price target of $21.72.

Get Our Latest Research Report on ADNT

Adient Profile

(Free Report)

Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.

Further Reading

Institutional Ownership by Quarter for Adient (NYSE:ADNT)

Should You Invest $1,000 in Adient Right Now?

Before you consider Adient, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Adient wasn't on the list.

While Adient currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines